Keyphrases
Glioblastoma
100%
Tumor
81%
Medulloblastoma
76%
Sex Differences
72%
Brain Tumor
55%
Glioma
47%
Neurofibromatosis Type 1 (NF-1)
46%
C-X-C Chemokine Receptor Type 4 (CXCR4)
44%
In Cancer
37%
Mouse Model
35%
Sex-specific
34%
Focused Ultrasound
31%
Chemokine Ligand 12 (CXCL12)
31%
Sonic Hedgehog
30%
Pediatric Brain Tumor
27%
Temozolomide
26%
Neurofibromatosis Type I
26%
Radiation Therapy
23%
Glioma Growth
22%
Overall Survival
21%
Primary Brain Tumor
19%
Tumor Cells
18%
Pediatric
17%
Optic Pathway Glioma
17%
Tumor Growth
17%
Astrocytes
16%
Gliomagenesis
16%
Metabolism
15%
Newly Diagnosed Glioblastoma
15%
Progression-free Survival
14%
Blood-brain Barrier
13%
Endothelial Cells
13%
Sexually Dimorphic
13%
Functional Connectivity
13%
Cyclic Adenosine Monophosphate (cAMP)
13%
Diffuse Intrinsic Pontine Glioma
13%
Pilocytic Astrocytoma
12%
Chemotherapy
12%
Gross Total Resection
12%
Microenvironment
12%
Gold Nanoclusters
12%
Malignant Glioma
12%
Sonic Hedgehog Medulloblastoma
12%
Glioma Risk
12%
Medulloblastoma Subgroups
12%
Glioma Model
11%
Brain Tumorigenesis
11%
Brainstem
11%
Resting-state Functional Connectivity (rs-FC)
11%
Disulfiram
11%
Medicine and Dentistry
Neoplasm
85%
Ganglioglioma
53%
Medulloblastoma
47%
Glioblastoma
46%
Intracranial Tumor
40%
Malignant Neoplasm
39%
Sex Difference
37%
Pediatrics
30%
Neurofibromatosis Type I
27%
Diseases
27%
Overall Survival
20%
Surgery
20%
Sonic Hedgehog Protein
18%
Carcinogenesis
16%
Cancer
16%
Tumor Progression
16%
Gender and Sex
15%
Radiation Therapy
13%
Treatment Response
12%
Pilocytic Astrocytoma
12%
Biopsy Technique
12%
Blood Brain Barrier
12%
Pediatric Brain Tumor
12%
Copper 64
11%
Bevacizumab
10%
Endothelial Cell
10%
Progression Free Survival
9%
Medicine
8%
Temozolomide
8%
Tumor Cell
7%
Recurrent Disease
7%
Functional Connectivity
7%
Meningioma
7%
Pontine Glioma
7%
Nervous System Tumor
7%
Sex Hormone
7%
Angiogenesis Inhibitor
6%
Prognostic Factor
6%
Gene Mutation
6%
Clinical Trial
6%
Central Nervous System Tumor
6%
U87
5%
Platelet Derived Growth Factor Receptor
5%
Cell Interaction
5%
Quality of Life
5%
Epidermal Growth Factor Receptor
5%
Positron Emission Tomography
5%
Antiangiogenic
5%
Cancer Therapy
5%
Chronotherapy
5%